Literature DB >> 17522872

[Changes for the field of rheumatology in the G-DRG-System 2007].

A Liedtke-Dyong1, W Fiori, H-J Lakomek, A Wenke, W Liman, N Roeder.   

Abstract

After extensive revision the partners of the self-administration"Selbstverwaltung" reached an amicable agreement on the new version 2007 of the G-DRG system. Like in the years before, version 2007 brings about large-scale changes for its users. A better representation of inpatient services in Germany combined with an improved economic homogeneity and appropriateness can be assumed. This is based on various factors, e. g. considerably increased data-quality and the optimization of technical influences on the system. Due to the rising level of complexity it is hardly possible to maintain a clinically homogeneous classification on the basis of G-DRGs. There is need [This calls] for a new approach in strategic matters. Various initiatives succeeded in a continuous improvement how the services provided by specialised rheumatologic clinics and departments are represented in the G-DRG system. Meanwhile, even under the pressure caused by the period of convergence, quality standards were focused on as well. The systematic changes of version 2007 as well as modifications concerning co-payments, coding and accounting rules relevant for rheumatologic clinics are presented and the consequences for users are discussed.

Mesh:

Year:  2007        PMID: 17522872     DOI: 10.1007/s00393-007-0173-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  8 in total

1.  [Appropriate representation of rheumatology in the G-DRG system].

Authors:  H-J Lakomek; N Roeder; W Liman; W L Gross
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

2.  [Rheumatologic treatment in the G-DRG system].

Authors:  N Roeder; W Fiori; J L Hülsemann; N Könecke; H Lehmann; W Liman; H-J Lakomek
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

3.  [The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

Authors:  H-J Lakomek; W Fiori; K Buscham; J L Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

4.  [What changes for rheumatologists in the G-DRG system 2006?].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; J L Hülsemann; N Köneke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

5.  [Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

Authors:  H J Lakomek; W Fiori; K Buscham; J Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

6.  [Do we need in-patient rheumatology?].

Authors:  H-J Lakomek
Journal:  Dtsch Med Wochenschr       Date:  2006-10-13       Impact factor: 0.628

Review 7.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

8.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.